Amgen reported $4.02B in Stock for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Agios Pharmaceuticals AGIO:US $ 16.19M 1.49M
ALKERMES ALKS:US $ 134.18M 8.44M
Amgen AMGN:US $ 4017M 124M
Biogen BIIB:US $ 1171.8M 103.2M
Biomarin Pharmaceutical BMRN:US $ 713.93M 15.38M
Bristol Myers Squibb BMY:US $ 1953M 121M
Eli Lilly And LLY:US $ 3660.8M 319.5M
Gilead Sciences GILD:US $ 2996M 1313M
GlaxoSmithKline GSK:LN 6216M 220M
Johnson & Johnson JNJ:US $ 9952M 608M
Moderna Inc MRNA:US 494M 447.47M
Neurocrine Biosciences NBIX:US $ 30.1M 2.1M
Novartis NOVN:VX SF 6997M 134M
Ptc Therapeutics PTCT:US $ 16.23M 2.46M
Puma Biotechnology PBYI:US $ 7.74M 4.29M
Regeneron Pharmaceuticals REGN:US $ 2164.7M 679M
Teva Pharmaceutical TEVA:IT 4.41B 3M
Ultragenyx Pharmaceutical RARE:US $ 12.46M 0.59M
Vertex Pharmaceuticals VRTX:US $ 298.86M 18.09M